654 A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors

Slični predmeti

• 654 A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors
  od: Marcus Butler, i dr.
  Izdano: (2023-11-01)
• Novel Claudin18.2-Targeted Therapies in Gastrointestinal Tumors
  od: Wei Ye, i dr.
  Izdano: (2025-09-01)
• Heterogeneity of claudin 18.2 expression in metastatic gastric cancer
  od: Eugene Choi, i dr.
  Izdano: (2024-07-01)
• Claudin18.2： an emerging target for the treatment of gastric cancer
  od: WANG Qiangcheng, BAO Jun
  Izdano: (2024-02-01)
• 659 Repeated dosing of anti-Claudin 18.2 CAR-T in metastatic gastrointestinal cancer
  od: Dan Zhao, i dr.
  Izdano: (2023-11-01)